Furex-1.5 gm (IV): Cefuroxime Sodium USP 1.5 gm/vial Injection.
Furex is indicated in the treatment of : Upper respiratory tract infections : Ear, nose, throat infections, such as otitis media, sinusitis, tonsillitis and pharyngitis. Lower respiratory tract infections : Acute and chronic bronchitis and pneumonia. Genito-urinary tract infections : Pyelonephritis, cystitis and urethritis, gonorrhoea, acute uncomplicated gonococcal urethritis and cervicitis. Skin and soft tissue infection : Impetigo. Lyme disease : Erythema marginatum.
Furex-1.5 gm (IV): Cefuroxime Sodium USP 1.5 gm/vial Injection.
Furex is indicated in the treatment of : Upper respiratory tract infections : Ear, nose, throat infections, such as otitis media, sinusitis, tonsillitis and pharyngitis. Lower respiratory tract infections : Acute and chronic bronchitis and pneumonia. Genito-urinary tract infections : Pyelonephritis, cystitis and urethritis, gonorrhoea, acute uncomplicated gonococcal urethritis and cervicitis. Skin and soft tissue infection : Impetigo. Lyme disease : Erythema marginatum.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.